Prostate Cancer : Episode 11

Video

Episode 11 - Personalized Medicine in CRPC

During this segment, the panelists explore the use of personalized medicine in castration-resistant prostate cancer.

Jeffrey D. Dunn, PharmD, MBA, and Raoul S. Concepcion, MD, explain that clinicians hope to have better data available in the future to provide definitive answers about treatment options for specific patient populations.

Dr Concepcion explains the variables that are being reviewed to help clinicians make wiser treatment decisions for their patients.

However, E. David Crawford, MD, reminds the panelists why achieving this goal will not be easy.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
ASCO 2025
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Related Content
FDA approval-Olivier Le Moal-stock.adobe.com.jpeg
June 12th 2025

Mitomycin Intravesical Solution Gains FDA Approval for Recurrent Low-Grade NMIBC

Giuliana Grossi
The FDA approved mitomycin intravesical solution (Zusduri) for patients with recurrent low-grade intermediate risk non–muscle-invasive bladder cancer (NMIBC).
managed care cast logo
June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS
Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Medicine doctor analysis and diagnosis checking health of patient online and testing result with modern virtual interface on laptop with stethoscope in hand, Online Medical global network - ipopba - stock.adobe.com.jpeg
June 11th 2025

Dual-Biomarker Approach Best for Equitable Kidney Disease Risk Assessment, New Data Find

Giuliana Grossi
Race-free kidney function equations may underestimate risks for Black adults according to a new analysis.
Managed Care Cast
June 3rd 2025

Managed Care Cast News Roundup: June 3, 2025

Giuliana Grossi
A quick roundup episode of major health policy developments, from shifting COVID-19 vaccine guidance and scientific publishing controversies to rising cancer care costs and the impact of oncology biosimilars.
Echocardiography | Image Credit: Tamer-stock.adobe.com
June 11th 2025

TPIP a Potential Game-Changer for Prostanoid Therapy in PAH

Victoria Johnson
Treprostinil palmitil inhalation powder (TPIP) for pulmonary arterial hypertension (PAH) showed promising results in a midstage clinical trial, significantly improving key measures of heart and lung function.
AJMC
June 11th 2025

Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model

Brigham Walker, PhD Lalan Wilfong, MD Nicholas Robert, MD Alexander Siebert, PhD J. Russell Hoverman, MD, PhD
A private oncology shared savings plan reduced colon cancer treatment costs. Results varied by tumor, with none in breast cancer and mixed effects in lung cancer.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo